Riddell, A.; McBride, M.; Braun, T.; Nicklin, S. A.; Cameron, E.; Loughrey, C. M.; Martin, T. P.: RUNX1: an emerging therapeutic target for cardiovascular disease. CARDIOVASCULAR RESEARCH 116 (8), pp. 1410 - 1423 (2020)
Good, D. J.; Zhang, H.; Grange, R. W.; Braun, T.: Pro-opiomelanocortin Neurons and the Transcriptional Regulation of Motivated Exercise. EXERCISE AND SPORT SCIENCES REVIEWS 48 (2), pp. 74 - 82 (2020)
Moore, J. B.; Sadri, G.; Fischer, A. G.; Weirick, T.; Militello, G.; Wysoczynski, M.; Gumpert, A. M.; Braun, T.; Uchida, S.: The A-to-I RNA Editing Enzyme Adar1 Is Essential for Normal Embryonic Cardiac Growth and Development. CIRCULATION RESEARCH 127 (4), pp. 550 - 552 (2020)
Richter, A. M.; Woods, M. L.; Kuester, M. M.; Walesch, S. K.; Braun, T.; Boettger, T.; Dammann, R. H.: RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice. ONCOGENE 39 (15), pp. 3114 - 3127 (2020)
A team of researchers at the Max Planck Institute for Heart and Lung Research, led by Prof. Dr. Didier Y.R. Stainier, has been awarded a prestigious ERC Proof of Concept (PoC) grant to advance a groundbreaking RNA-based therapeutic strategy for Duchenne Muscular Dystrophy (DMD).